3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
4
Recurrence
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Triple Negative Breast Neoplasms
1
Spinal Cord Neoplasms
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Ovarian Neoplasms
1
Neurofibromatosis 1
1
Neoplasms, Squamous Cell
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
HR+/HER2- Breast Cancer
1
Glioma
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Brain Diseases
1
Interventions
Rituximab
12
Cyclophosphamide
12
Biopsy
12
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
fludarabine
7
Lenalidomide
7
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
fludarabine phosphate
4
X-Rays
4
Tacrolimus
4
Mycophenolic Acid
4
Doxorubicin
4
Busulfan
4
venetoclax
3
ibrutinib
3
glofitamab
3
acalabrutinib
3
Whole-Body Irradiation
3
Vincristine
3
GSK2636771
3
Etoposide
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
abemaciclib
×
30 days
×
Clear all
No trials found.